The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Hospital in Qingdao
Shandong, Qingdao, Shinan District, 江苏路16号 邮政编码 - 266005
About The Affiliated Hospital of Qingdao University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
The Affiliated Hospital of Qingdao University
33
Qingdao University
13
BeiGene
7
Hoffmann-La Roche
6
Jiangsu HengRui Medicine Co., Ltd.
6
Takeda
5
Beijing Chao Yang Hospital
4
Pfizer
4
Qilu Hospital of Shandong University
4
Shanghai Junshi Bioscience Co., Ltd.
4
Advenchen Laboratories Nanjing Ltd.
3
Clinical Trials at The Affiliated Hospital of Qingdao University
During the past decade, The Affiliated Hospital of Qingdao University conducted 180 clinical trials. In the 10-year time frame, 180 clinical trials started and 14 clinical trials were completed, i.e. on
average, 7.8% percent of trials that started reached the finish line to date. In the past 5 years, 108 clinical trials started and 8 clinical trials were completed. i.e. 7.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
2003-03-01
Terminated
750
Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
2002-06-01
2006-02-01
Completed
274
12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
2002-06-01
2006-02-01
Completed
129
Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)
2006-06-01
2009-05-01
Completed
83
Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China
2011-02-09
2018-11-30
Completed
564
Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot
2011-01-01
2013-07-01
Unknown status
50
Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
2010-10-01
2012-12-01
Unknown status
30
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Affiliated Hospital of Qingdao University" #1 sponsor was "The Affiliated Hospital of Qingdao University" with 33 trials, followed by "Qingdao University" with 13 trials
sponsored, "BeiGene" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored and "Jiangsu HengRui Medicine Co., Ltd."
with 6 trials sponsored. Other sponsors include 145 different institutions and
companies that sponsored additional 111 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Affiliated Hospital of Qingdao University"
#1 collaborator was "The Affiliated Hospital of Qingdao University" with 10 trials as a collaborator, "Chinese PLA General Hospital" with 5 trials as a collaborator, "Fujian Medical University Union Hospital" with 5 trials as a collaborator, "Ruijin Hospital" with 5 trials as a collaborator and "Shandong Provincial Hospital" with 5 trials as a collaborator. Other collaborators include 340 different institutions and companies that were
collaborators in the rest 239 trials.
Clinical Trials Conditions at The Affiliated Hospital of Qingdao University
According to Clinical.Site data, the most researched conditions in "The Affiliated Hospital of Qingdao University" are
"Breast Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Healthy" (4 trials), "Mesenchymal Stem Cells" (4 trials) and "Non-small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "The Affiliated Hospital of Qingdao University" in a lesser frequency.
Clinical Trials Intervention Types at The Affiliated Hospital of Qingdao University
Most popular intervention types in "The Affiliated Hospital of Qingdao University" are "Drug" (128 trials), "Other" (21 trials), "Device" (18 trials), "Procedure" (16 trials) and "Biological" (12 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (25 trials), "Tislelizumab" (7 trials), "Docetaxel" (5 trials), "Capecitabine" (4 trials) and "Cisplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at The Affiliated Hospital of Qingdao University
The vast majority of trials in "The Affiliated Hospital of Qingdao University" are
199 trials for "All" genders, 9 trials for "Female" genders and 7 trials for "Male" genders.
Clinical Trials Status at The Affiliated Hospital of Qingdao University
Currently, there are 107 active trials in "The Affiliated Hospital of Qingdao University".
14 are not yet recruiting,
70 are recruiting,
20 are Active, not recruiting,
and 3 are Enrolling by invitation.
In total, there were 62 completed trials in The Affiliated Hospital of Qingdao University,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in The Affiliated Hospital of Qingdao University, 41 "Phase 1"
clinical trials were conducted, 45 "Phase 2" clinical
trials and 59 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 13 trials, and there were
also 35 trials that are defined as “Not Applicable".